Biomerieux SA
F:EYW
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biomerieux SA
F:EYW
|
FR |
Intrinsic Value
The intrinsic value of 
Biomerieux SA (EYW) under the Base Case is 271.407 EUR per share.
Compared with the current market price of 206.421 EUR, the stock appears
Undervalued by 24% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Biomerieux Does
bioMérieux makes laboratory tests that help doctors and companies find microbes and understand whether a sample is safe. Its products include testing instruments, disposable reagents, software, and service contracts. In hospitals and public labs, these tests are used to identify infections and guide treatment decisions.
- Headquarters
- France FR
- Employees
- 14 894
- IPO date
- Jun 7, 2004
Biomerieux has no economic moat
Hospitals, laboratories and industrial customers can choose among competing diagnostic systems, and bioMérieux’s products do not become more valuable just because more customers use them. Its strong presence in some areas does not prevent rivals from competing for buyers or guarantee that customers will pay more for its name alone.
Read the full moat analysis
Earnings Waterfall
Biomerieux SA
The intrinsic value for Biomerieux SA (EYW) under the Base Case is 271.407 EUR.
Compared with the current market price of 206.421 EUR, the stock appears Undervalued by 24% .